Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you're wondering whether taking Wegovy before bed makes any practical difference, the short answer is: the timing of your weekly injection is flexible. Wegovy (semaglutide) stays active in your body for seven days, so the clock on the wall matters far less than consistency from week to week. There is no clinical evidence that an evening injection produces better weight loss than a morning one. That said, some people do find that injecting before sleep softens the nausea that can follow a new dose or a dose increase, simply because they sleep through the worst of the first few hours. These are prescription-only medicines, though, and any decisions about your injection routine belong in a conversation with the prescriber who knows your full medical picture.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture this: it's 10pm, you've done your weekly Wegovy injection, and an hour later you're lying in bed feeling queasy, with a faint headache creeping in. You're wondering whether you chose the wrong time of day, and whether changing to a morning injection would fix it.
It's a genuinely common experience, and the frustrating truth is that there is no universally correct time. Wegovy's active ingredient, semaglutide, is absorbed slowly after a subcutaneous injection and reaches peak plasma concentration after one to three days. After that it tails off gradually over the rest of the week. The NHS medicines guidance on semaglutide confirms that the injection can be given at any time of day, with or without food, and the day of the week can be changed if needed as long as the gap between doses stays at least two days. What the licence does not specify is a preferred time of day, because the pharmacology does not demand one.
So the bedtime strategy is not a clinical recommendation so much as a practical one. If nausea is your main concern after starting or stepping up, injecting in the evening and sleeping through the first few hours can make those hours more bearable. That is a reasonable approach, provided your sleep itself is not then being disrupted by discomfort.
For a broader look at what to think about before each injection, the page on what to do before taking Wegovy covers preparation and routine in more detail.
Wegovy is injected once weekly, subcutaneously, into the abdomen, thigh or upper arm. The maintenance pathway runs from 0.25mg up through 0.5mg, 1.0mg, 1.7mg and 2.4mg, with each step typically held for around four weeks before the prescriber decides whether to move up. The 7.2mg dose, approved by the MHRA in April 2026 as a dedicated single-dose pen, sits above that as a higher maintenance option for adults with a BMI of 30 or above.
Within that schedule, time of day is genuinely secondary. The variable that matters most is keeping the same day each week. Your body adapts to a rhythm of weekly peaks and troughs in semaglutide concentration, and drifting the injection day by two or three days repeatedly will create an uneven pattern. Most people anchor their injection to something predictable: a Sunday evening television programme, a Monday morning alarm, or a Friday after work. The specific hook matters less than the consistency.
It is worth keeping the pen in the fridge door at a steady 2–8°C between uses, taking it out fifteen to thirty minutes before you inject makes the injection more comfortable, and that small habit is easier to build around a fixed time of day. For the exact storage window at room temperature, always check your patient information leaflet rather than relying on general guidance, because the permitted window can differ between pen presentations.
Those exploring whether a night-time injection fits their lifestyle often find the dedicated page on whether it is OK to take Wegovy before bed useful for the practical detail.
The most commonly reported side effects of Wegovy are gastrointestinal: nausea, vomiting, diarrhoea, constipation, indigestion and burping. The STEP 1 trial, published in the New England Journal of Medicine, reported these effects in a significant proportion of participants, particularly after dose increases, and noted they were typically mild to moderate and settled over time. Injecting before bed does not eliminate these effects; it shifts when you experience them.
If bedtime injections are leaving you waking repeatedly through the night with nausea or abdominal discomfort, that is not simply a timing problem, it may mean the dose increase is happening too quickly for your system, and your prescriber needs to know. The same applies to any persistent, severe stomach pain that radiates through to the back: that symptom requires urgent medical assessment and is not something to manage at home by changing your injection time.
On a lighter note, dizziness or light-headedness in the hours after an injection is worth accounting for before you decide on an evening routine. If you inject at 9pm and feel dizzy by 10pm, going to bed is an entirely sensible response. If that timing is inconvenient, a different slot in the evening is fine. For a fuller picture of how semaglutide works in the body, the semaglutide overview covers the mechanism in plain terms.
Anyone considering Wegovy for the first time, or who has questions about their current routine, can review the weight-loss treatment options available through a clinically supervised private route.
There are no randomised trials comparing evening versus morning Wegovy injections as such, the clinical programme tested efficacy over weeks and months, not time-of-day sub-groups. What exists is accumulated clinical observation and patient experience, which consistently points in the same direction: people who struggle with nausea tend to prefer evenings; people who prefer to tick a task off first thing tend to prefer mornings; people with shift work or irregular schedules anchor to a fixed day but not a fixed hour.
Neither group performs differently in terms of weight outcomes, as you would expect given the pharmacokinetics. The Wegovy results evidence page discusses what the clinical trials actually demonstrated in terms of weight change, which is where the meaningful variation lives, not in the clock.
If cost is part of your thinking, the Wegovy cost guide explains what a legitimate private prescription typically includes and why the price varies between providers. The question of whether to inject at 8am or 10pm is unlikely to appear on that page, which is as it should be.
For anyone comparing the injection and tablet forms of semaglutide, a look at the full Wegovy treatment page sets out both options and what the licensed indications cover.
Our prescribers review every consultation personally and can discuss injection timing, side-effect management and dose progression with you directly. If you have questions your current prescriber has not fully addressed, or you are thinking about starting treatment, you are welcome to speak to our prescribers through a free consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.